These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31342586)

  • 1. A porcine xenograft-derived bone scaffold is a biocompatible bone graft substitute: An assessment of cytocompatibility and the alpha-Gal epitope.
    Bracey DN; Seyler TM; Jinnah AH; Smith TL; Ornelles DA; Deora R; Parks GD; Van Dyke ME; Whitlock PW
    Xenotransplantation; 2019 Sep; 26(5):e12534. PubMed ID: 31342586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of reduction in the alpha-gal antigen on bony union: a model of xenobone graft using GalT knockout mouse.
    Park MS; Kim TG; Lee KM; Chung CY; Kwon SS; Yoon IH; Park CG
    Xenotransplantation; 2014; 21(3):267-73. PubMed ID: 24635119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Development of a Xenograft-Derived Scaffold for Tendon and Ligament Reconstruction Using a Decellularization and Oxidation Protocol.
    Seyler TM; Bracey DN; Plate JF; Lively MO; Mannava S; Smith TL; Saul JM; Poehling GG; Van Dyke ME; Whitlock PW
    Arthroscopy; 2017 Feb; 33(2):374-386. PubMed ID: 27692557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GGTA1/iGb3S Double Knockout Mice: Immunological Properties and Immunogenicity Response to Xenogeneic Bone Matrix.
    Shao A; Ling Y; Chen L; Wei L; Fan C; Lei D; Xu L; Wang C
    Biomed Res Int; 2020; 2020():9680474. PubMed ID: 32596401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Osteoinductive Potential of a Decellularized Xenograft Bone Substitute.
    Bracey DN; Jinnah AH; Willey JS; Seyler TM; Hutchinson ID; Whitlock PW; Smith TL; Danelson KA; Emory CL; Kerr BA
    Cells Tissues Organs; 2019; 207(2):97-113. PubMed ID: 31655811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Decellularized Porcine Xenograft-Derived Bone Scaffold for Clinical Use as a Bone Graft Substitute: A Critical Evaluation of Processing and Structure.
    Bracey DN; Seyler TM; Jinnah AH; Lively MO; Willey JS; Smith TL; Van Dyke ME; Whitlock PW
    J Funct Biomater; 2018 Jul; 9(3):. PubMed ID: 30002336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone xenotransplantation: A review of the history, orthopedic clinical literature, and a single-center case series.
    Bracey DN; Cignetti NE; Jinnah AH; Stone AV; Gyr BM; Whitlock PW; Scott AT
    Xenotransplantation; 2020 Sep; 27(5):e12600. PubMed ID: 32372420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A porcine-derived acellular dermal scaffold that supports soft tissue regeneration: removal of terminal galactose-alpha-(1,3)-galactose and retention of matrix structure.
    Xu H; Wan H; Zuo W; Sun W; Owens RT; Harper JR; Ayares DL; McQuillan DJ
    Tissue Eng Part A; 2009 Jul; 15(7):1807-19. PubMed ID: 19196142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of α-Gal Antigen Removal in the Porcine Dermal Tissue by α-Galactosidase.
    Gao HW; Li SB; Sun WQ; Yun ZM; Zhang X; Song JW; Zhang SK; Leng L; Ji SP; Tan YX; Gong F
    Tissue Eng Part C Methods; 2015 Nov; 21(11):1197-204. PubMed ID: 26140655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of impact of animal source on physical, structural, and biological properties of bone xenograft.
    Gashtasbi F; Hasannia S; Hasannia S; Mahdi Dehghan M; Sarkarat F; Shali A
    Xenotransplantation; 2020 Nov; 27(6):e12628. PubMed ID: 32654298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation.
    Stone KR; Abdel-Motal UM; Walgenbach AW; Turek TJ; Galili U
    Transplantation; 2007 Jan; 83(2):211-9. PubMed ID: 17264818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.
    Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J
    J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of alpha-gal xenoreactive epitope: alpha-galactosidase treatment of porcine heart valves.
    Choi SY; Jeong HJ; Lim HG; Park SS; Kim SH; Kim YJ
    J Heart Valve Dis; 2012 May; 21(3):387-97. PubMed ID: 22808845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pig-to-rhesus lamellar corneal xenotransplantation.
    Choi HJ; Kim MK; Lee HJ; Ko JH; Jeong SH; Lee JI; Oh BC; Kang HJ; Wee WR
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6643-50. PubMed ID: 21743020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic pigs designed to express human α-galactosidase to avoid humoral xenograft rejection.
    Zeyland J; Gawrońska B; Juzwa W; Jura J; Nowak A; Słomski R; Smorąg Z; Szalata M; Woźniak A; Lipiński D
    J Appl Genet; 2013 Aug; 54(3):293-303. PubMed ID: 23780397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenogeneic bone matrix immune risk assessment using GGTA1 knockout mice.
    Shao A; Ling Y; Xu L; Liu S; Fan C; Wang Z; Xu B; Wang C
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S359-S369. PubMed ID: 30207744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of the alpha-gal epitope on adult porcine bone tissue.
    Feng W; Lian Y; Zhou Z; Lu Y; Li S; Pei F; Cheng J
    Transplant Proc; 2006 Sep; 38(7):2247-51. PubMed ID: 16980056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcification of decellularized and alpha-galactosidase-treated bovine pericardial tissue in an alpha-Gal knock-out mouse implantation model: comparison with primate pericardial tissue.
    Kim MS; Lim HG; Kim YJ
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):894-900. PubMed ID: 25994817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microencapsulated adult porcine islets transplanted intraperitoneally in streptozotocin-diabetic non-human primates.
    Safley SA; Kenyon NS; Berman DM; Barber GF; Willman M; Duncanson S; Iwakoshi N; Holdcraft R; Gazda L; Thompson P; Badell IR; Sambanis A; Ricordi C; Weber CJ
    Xenotransplantation; 2018 Nov; 25(6):e12450. PubMed ID: 30117193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel reconstituted bone xenograft using processed bovine cancellous bone in combination with purified bovine bone morphogenetic protein.
    Long B; Dan L; Jian L; Yunyu H; Shu H; Zhi Y
    Xenotransplantation; 2012; 19(2):122-32. PubMed ID: 22497514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.